Dabur abort ties with Hospira

New Delhi, May 5 (UNI) Dabur Oncology Plc, a wholly-owned subsidiary of Dabur Pharma today said the sales and distribution agreement with Hospira Inc has been terminated with mutual consent.

The agreement between the two companies was for an exclusive supply of oncology products for sales and distribution in the US market.

The company will now sell and distribute its entire range of oncology products in the US through its own infrastructure, a statement said.

UNI